Congress Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
10,247
-1,619,238
-99% -$87.9M ﹤0.01% 337
2026
Q1
$102M Sell
1,629,485
-20,473
-1% -$1.64M 0.73% 39
2025
Q4
$157M Sell
1,649,958
-34,119
-2% -$3.35M 1.11% 17
2025
Q3
$164M Sell
1,684,077
-17,493
-1% -$1.81M 1.09% 18
2025
Q2
$183M Sell
1,701,570
-17,258
-1% -$1.75M 1.25% 16
2025
Q1
$173M Sell
1,718,828
-3,364
-0.2% -$339K 1.3% 9
2024
Q4
$154M Buy
1,722,192
+3,538
+0.2% +$311K 1.04% 18
2024
Q3
$144M Buy
1,718,654
+53,346
+3% +$4.21M 0.98% 24
2024
Q2
$128M Buy
1,665,308
+155,829
+10% +$11.4M 0.92% 39
2024
Q1
$103M Buy
1,509,479
+31,615
+2% +$2.03M 0.74% 62
2023
Q4
$85.4M Buy
1,477,864
+33,214
+2% +$1.77M 0.67% 70
2023
Q3
$76.3M Buy
1,444,650
+1,439,830
+29,872% +$75.5M 0.67% 74
2023
Q2
$261K Hold
4,820
﹤0.01% 357
2023
Q1
$241K Hold
4,820
﹤0.01% 363
2022
Q4
$223K Buy
+4,820
New +$209K ﹤0.01% 371

Other funds holding BSX

Congress Asset Management's BSX Position: Q2 2026 in Review

Congress Asset Management reduced its Boston Scientific (BSX) stake by 99% in Q2 2026, selling an estimated $87.9M and leaving 10,247 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Congress Asset Management first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $183M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Congress Asset Management held 10,247 shares of Boston Scientific worth $437K as of Q2 2026.
  • Congress Asset Management sold 1,619,238 Boston Scientific shares in Q2 2026, an estimated $87.9M.
  • Boston Scientific made up ﹤0.01% of Congress Asset Management's portfolio in Q2 2026, its #337 holding.
  • Congress Asset Management first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Congress Asset Management's Boston Scientific position peaked at $183M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.